Haiyang Guo

3.8k total citations · 1 hit paper
58 papers, 1.5k citations indexed

About

Haiyang Guo is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Haiyang Guo has authored 58 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 13 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in Haiyang Guo's work include RNA modifications and cancer (9 papers), Epigenetics and DNA Methylation (7 papers) and Cancer-related molecular mechanisms research (5 papers). Haiyang Guo is often cited by papers focused on RNA modifications and cancer (9 papers), Epigenetics and DNA Methylation (7 papers) and Cancer-related molecular mechanisms research (5 papers). Haiyang Guo collaborates with scholars based in China, United States and Canada. Haiyang Guo's co-authors include Changshun Shao, Zhaojian Liu, Yaoqin Gong, Xiyu Zhang, Yongxin Zou, Qifeng Yang, Housheng Hansen He, Dongliang Yang, Beihua Kong and Bing Xu and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Haiyang Guo

48 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recent design strategies for boosting chemodynamic therapy of bacterial infections

2023 92 citations Junjie Zhang, Haiyang Guo et al. SHILAP Revista de lepidopterología profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Haiyang Guo China	23	832	399	267	184	170	58	1.5k
Xiaoli Zhu China	22	948 1.1×	689 1.7×	208 0.8×	140 0.8×	206 1.2×	57	1.6k
Laura Pop Romania	19	621 0.7×	416 1.0×	223 0.8×	102 0.6×	129 0.8×	69	1.2k
Naoyo Nishida Japan	12	837 1.0×	366 0.9×	401 1.5×	151 0.8×	140 0.8×	27	1.5k
Feifei Li China	27	1.4k 1.7×	453 1.1×	241 0.9×	195 1.1×	146 0.9×	120	2.2k
Sundaramoorthy Revathidevi India	10	603 0.7×	298 0.7×	146 0.5×	74 0.4×	110 0.6×	16	1.0k
Songling Zhang China	20	662 0.8×	307 0.8×	158 0.6×	95 0.5×	94 0.6×	67	1.1k
Vijay Pandey China	30	1.4k 1.7×	706 1.8×	658 2.5×	137 0.7×	226 1.3×	105	2.5k
Reza Nedaeinia Iran	19	942 1.1×	650 1.6×	345 1.3×	239 1.3×	132 0.8×	52	1.7k
Huirong Shi China	23	1.1k 1.3×	556 1.4×	421 1.6×	81 0.4×	131 0.8×	91	1.6k
Girijesh Kumar Patel United States	19	1.2k 1.5×	723 1.8×	300 1.1×	183 1.0×	179 1.1×	48	1.7k

Countries citing papers authored by Haiyang Guo

Since Specialization

Citations

This map shows the geographic impact of Haiyang Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haiyang Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haiyang Guo more than expected).

Fields of papers citing papers by Haiyang Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haiyang Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haiyang Guo. The network helps show where Haiyang Guo may publish in the future.

Co-authorship network of co-authors of Haiyang Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Haiyang Guo. A scholar is included among the top collaborators of Haiyang Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haiyang Guo. Haiyang Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wei, Wenjing, et al.. (2025). Transcriptional landscape and chromatin accessibility reveal key regulators for liver regenerative initiation and organoid formation. Cell Reports. 44(5). 115633–115633.

Li, Xiaojun, Xue Zhang, Haina Tang, et al.. (2025). Regulation of macrophage phenotypes via NF-κB/NLRP3 and HIF1α/p53 pathways by fuco-galactoglucan from Agrocybe aegerita. International Journal of Biological Macromolecules. 322(Pt 2). 146559–146559.

Guo, Haiyang, et al.. (2025). Bioactive Polysaccharides From Cremastra Appendiculata Attenuate Lipid Accumulation In Vitro Model of Non‐Alcoholic Fatty Liver Disease. Chemistry & Biodiversity. 22(6). e202402772–e202402772.

Tang, Haina, Feng Gu, Suqin Liu, et al.. (2025). Structural elucidation of an Astragalus acidic polysaccharide and its anti-colon cancer activity through modulation of JNK/MAPK and NLRP3/IL-1β signaling pathways. Chemical and Biological Technologies in Agriculture. 12(1).

Guo, Haiyang, Jie Li, Jinhong Sun, et al.. (2024). Downregulation of RCN1 inhibits esophageal squamous cell carcinoma progression and M2 macrophage polarization. PLoS ONE. 19(5). e0302780–e0302780. 3 indexed citations

Liu, Chenxu, et al.. (2024). FOXA1 regulates ribosomal RNA transcription in prostate cancer. The Prostate. 84(10). 967–976.

Luo, Zichen, Xiaobo Wang, Shiqi Liang, et al.. (2024). Analyzing risk factors and constructing a predictive model for superficial esophageal carcinoma with submucosal infiltration exceeding 200 micrometers. BMC Gastroenterology. 24(1). 350–350.

Guo, Haiyang, Lin Chen, Xiaobo Wang, et al.. (2023). Development and validation of a prognostic model for mitophagy-related genes in colon adenocarcinoma: A study based on TCGA and GEO databases. PLoS ONE. 18(4). e0284089–e0284089. 7 indexed citations

Hu, Yanling, Ying Zhao, Zhijing Zhang, et al.. (2023). Nanomaterials for photothermal cancer therapy. RSC Advances. 13(21). 14443–14460. 95 indexed citations

10.

Zhang, Junjie, Haiyang Guo, Shengke Li, et al.. (2023). Recent design strategies for boosting chemodynamic therapy of bacterial infections. SHILAP Revista de lepidopterología. 4(2). 20230087–20230087. 92 indexed citations breakdown →

11.

Rao‐Bhatia, Abilasha, Wei Zhao, Jungeun Kim, et al.. (2023). YAP targetome reveals activation of SPEM in gastric pre-neoplastic progression and regeneration. Cell Reports. 42(12). 113497–113497. 7 indexed citations

12.

Wang, Zixiang, Shourong Wang, Gang Lü, et al.. (2022). Splicing factor BUD31 promotes ovarian cancer progression through sustaining the expression of anti-apoptotic BCL2L12. Nature Communications. 13(1). 6246–6246. 27 indexed citations

13.

Guo, Haiyang, Xiaobo Wang, Xiaobo Wang, et al.. (2022). A novel prognostic model based on urea cycle-related gene signature for colorectal cancer. Frontiers in Surgery. 9. 1027655–1027655. 11 indexed citations

14.

Seo, Jieun, Lutao Du, Yunshan Wang, et al.. (2021). Uncovering the dosage-dependent roles of Arid1a in gastric tumorigenesis for combinatorial drug therapy. The Journal of Experimental Medicine. 218(6). 18 indexed citations

15.

Guo, Haiyang, Yiming Wu, Mannan Nouri, et al.. (2021). Androgen receptor and MYC equilibration centralizes on developmental super-enhancer. Nature Communications. 12(1). 7308–7308. 42 indexed citations

16.

Zhang, Hanwen, Ning Zhang, Ying Liu, et al.. (2019). Epigenetic Regulation of NAMPT by NAMPT-AS Drives Metastatic Progression in Triple-Negative Breast Cancer. Cancer Research. 79(13). 3347–3359. 107 indexed citations

17.

Guo, Haiyang, Catherine Streutker, Musaddeque Ahmed, et al.. (2019). Gastrointestinal transcription factors drive lineage-specific developmental programs in organ specification and cancer. Science Advances. 5(12). eaax8898–eaax8898. 26 indexed citations

18.

Li, Boxuan, Dong Hou, Haiyang Guo, et al.. (2017). Resveratrol sequentially induces replication and oxidative stresses to drive p53-CXCR2 mediated cellular senescence in cancer cells. Scientific Reports. 7(1). 208–208. 48 indexed citations

19.

Liu, Qiao, Haiyan Jiang, Zhaojian Liu, et al.. (2011). Berberine Radiosensitizes Human Esophageal Cancer Cells by Downregulating Homologous Recombination Repair Protein RAD51. PLoS ONE. 6(8). e23427–e23427. 75 indexed citations

20.

Li, Xiaoyan, Xiaoli Kong, Qiang Huo, et al.. (2011). Metadherin enhances the invasiveness of breast cancer cells by inducing epithelial to mesenchymal transition. Cancer Science. 102(6). 1151–1157. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact